Showing 111-120 of 333 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Assessing immunotherapeutic potential of a natural IgM antibody for the treatment of T1D | Johns Hopkins University | Abdel Hamad | Cures | 01-June-2024 to 31-January-2026 | $199.881,88 |
| Metabolic modulation of Tregs for improved immunotherapy in T1D | University of Utah | Maria Bettini | Cures | 01-June-2024 to 31-May-2025 | $187.487,77 |
| Exploration of Age-Related Pancreatic Beta Cell Diversity in T1D Using Spatial Transcriptomics | Beckman Research Institute of the City of Hope | Farooq Syed | Cures | 01-October-2024 to 30-September-2025 | $199.999,92 |
| GeLite: Glowing Engineered Luminescent Microgels for Transplant Evaluation | Regents of the University of Michigan | Maria Coronel | Cures | 01-June-2024 to 30-April-2026 | $200.000,00 |
| Northern California Breakthrough T1D Center of Excellence | The Regents of the University of California, San Francisco | Qizhi Tang | Cures | 01-October-2024 to 30-September-2028 | $6.000.000,00 |
| Low level engraftment of modified HSCs for continuous and omnipresent autoantigen exposure as requirements to establish tolerance | Trustees of Columbia University in the City of New York | Remi Creusot | Cures | 01-June-2024 to 31-January-2026 | $188.704,16 |
| Orally Delivered Glucose-Responsive Insulin | Wayne State University | Zhiqiang Cao | Improving Lives | 01-June-2024 to 31-May-2026 | $274.499,13 |
| Generation of vascularized, transplantable islets from human iPSC-derived beta and isogenic vasculogenic cells | The Regents of the University of California, San Francisco | Julie Sneddon | Cures | 01-July-2024 to 30-June-2026 | $600.000,00 |
| Mechanistic Etiologies Underlying the Impact of Verapamil to Preserve β Cell Function in Type 1 diabetes | Regents of the University of Minnesota | Antoinette Moran | Cures | 01-September-2024 to 31-August-2026 | $643.946,00 |
| A hybrid effectiveness implementation trial of an intervention to reduce diabetes-specific emotional distress. | Ann & Robert H. Lurie Children’s Hospital of Chicago | Jill Weissberg-Benchell | Improving Lives | 01-September-2024 to 31-August-2029 | $1.936.551,00 |